独特の脳皮質の微細構造の変化は,イディオパシーな正常圧力水頭症
Myong Hun Hahm1, Shin Young Jeong2, Suhyun Kim3
1Department of Radiology, Daekyung Imaging Center, Daegu, Republic of Korea.
Frontiers in neurology
|August 29, 2025
まとめ
病原性正常圧水頭症 (INPH) の患者は,アルツハイマー病と比較して異なる皮質平均拡散率 (MD) のパターンを示しています.
科学分野:
- 神経イメージング
- 神経学
- 医療診断
背景:
- Idiopathic normal- pressure hydrocephalus (INPH) とアルツハイマー病 (AD) は,高齢者における一般的な神経変性疾患である.
- INPHとADを区別することは,適切な治療と患者の管理に不可欠です.
- 拡散テンザー画像 (DTI) により検出可能な皮質の微細構造の変化は,微分診断マーカーを提供することができる.
研究 の 目的:
- INPH患者,AD患者,健康な対照群の間の皮質平均拡散率 (MD) の違いを調査する.
- INPHでMDが変化した特定の皮質領域を特定し,ADと区別することができます.
- INPHとADを区別する MDの変化の診断性能を評価する.
主な方法:
- DTIを含むMRIは,INPH患者42人,AD患者51人,健康な対照群23人に実施された.
- 脳の全部の皮質のMDを検査するために,表面ベースの分析が使用されました.
- INPH患者で観察されたMDの変化に基づいて,特定の関心領域 (ROI) が定義された.
主要な成果:
- INPH患者では,対照群と比較して,前頭部,頭部,部におけるMDの減少を示した.
- INPH患者は対照群と比較して,前頭部と側頭葉皮質の領域でMDが増加した (INPH MD HIGH ROI).
- INPH MD LOW ROIの平均MDは,0.857のAUCでINPHとADを効果的に区別しました.
結論:
- INPH患者では,皮質のMD変化の明確なパターンがある.
- 減少したMDを持つ皮質領域はINPHとADを正確に区別することができます.
- 皮質のMDを通して微細構造の整合性を評価することは,高齢者のINPHとADを区別するのに役立ちます.
関連する概念動画
01:14Increased Intracranial Pressure l: Introduction
30
Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component...
30
01:29Increased Intracranial Pressure ll: Pathophysiology
39
Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins...
39
01:19Cerebral Edema l: Introduction
34
Cerebral edema is a pathological increase in brain water content that disrupts intracranial pressure regulation and impairs neurological function. Because the cranial vault is rigid, even modest increases in tissue volume can compromise cerebral perfusion, distort neural structures, and initiate secondary injury. Cerebral edema develops through four principal mechanisms: vasogenic, cytotoxic, interstitial, and ionic.Vasogenic EdemaVasogenic edema arises from disruption of the blood–brain...
34
01:22Cerebral Edema ll: Pathophysiology
31
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this...
31
01:23Alzheimer Disease ll: Pathophysiology
42
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
42